Literature DB >> 30285291

Impact of eosinophil-peroxidase (EPX) deficiency on eosinophil structure and function in mouse airways.

Caroline M Percopo1, Julia O Krumholz1, Elizabeth R Fischer2, Laura S Kraemer1, Michelle Ma1, Karen Laky3, Helene F Rosenberg1.   

Abstract

Eosinophil peroxidase (EPX) is a major constituent of the large cytoplasmic granules of both human and mouse eosinophilic leukocytes. Human EPX deficiency is a rare, autosomal-recessive disorder limited to the eosinophil lineage. Our intent was to explore the impact of EPX gene deletion on eosinophil content, structure, and function. In response to repetitive intranasal challenge with a filtrate of the allergen, Alternaria alternata, we found significantly fewer eosinophils peripherally and in the respiratory tracts of EPX-/- mice compared to wild-type controls; furthermore, both the major population (Gr1-/lo ) and the smaller population of Gr1hi eosinophils from EPX-/- mice displayed lower median fluorescence intensities (MFIs) for Siglec F. Quantitative evaluation of transmission electron micrographs of lung eosinophils confirmed the relative reduction in granule outer matrix volume in cells from the EPX-/- mice, a finding analogous to that observed in human EPX deficiency. Despite the reduced size of the granule matrix, the cytokine content of eosinophils isolated from allergen-challenged EPX-/ - and wild-type mice were largely comparable to one another, although the EPX-/- eosinophils contained reduced concentrations of IL-3. Other distinguishing features of lung eosinophils from allergen-challenged EPX-/- mice included a reduced fraction of surface TLR4+ cells and reduced MFI for NOD1. Interestingly, the EPX gene deletion had no impact on eosinophil-mediated clearance of gram-negative Haemophilus influenzae from the airways. As such, although no clinical findings have been associated with human EPX deficiency, our findings suggest that further evaluation for alterations in eosinophil structure and function may be warranted. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  allergy; cytokine; inflammation

Mesh:

Substances:

Year:  2018        PMID: 30285291      PMCID: PMC6310085          DOI: 10.1002/JLB.3AB0318-090RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  69 in total

1.  NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.

Authors:  Anne Månsson Kvarnhammar; Terese Petterson; Lars-Olaf Cardell
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation.

Authors:  K L Denzler; M T Borchers; J R Crosby; G Cieslewicz; E M Hines; J P Justice; S A Cormier; K A Lindenberger; W Song; W Wu; S L Hazen; G J Gleich; J J Lee; N A Lee
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 3.  Ly6 family proteins in neutrophil biology.

Authors:  Pui Y Lee; Jun-Xia Wang; Emilio Parisini; Christopher C Dascher; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2013-03-29       Impact factor: 4.962

Review 4.  Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".

Authors:  James J Lee; Elizabeth A Jacobsen; Sergei I Ochkur; Michael P McGarry; Rachel M Condjella; Alfred D Doyle; Huijun Luo; Katie R Zellner; Cheryl A Protheroe; Lian Willetts; William E Lesuer; Dana C Colbert; Richard A Helmers; Paige Lacy; Redwan Moqbel; Nancy A Lee
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

5.  Toxic effect of the peroxidase-hydrogen peroxide-halide antimicrobial system on Mycobacterium leprae.

Authors:  S J Klebanoff; C C Shepard
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma.

Authors:  Chun Kwok Wong; Shuiqing Hu; Karen Ming-Lam Leung; Jie Dong; Lan He; Yi Jun Chu; Ida Miu-Ting Chu; Huai-Na Qiu; Kelly Yan-Ping Liu; Christopher Wai-Kei Lam
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

Review 7.  Functions of tissue-resident eosinophils.

Authors:  Peter F Weller; Lisa A Spencer
Journal:  Nat Rev Immunol       Date:  2017-09-11       Impact factor: 53.106

8.  Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo.

Authors:  Channing Yu; Alan B Cantor; Haidi Yang; Carol Browne; Richard A Wells; Yuko Fujiwara; Stuart H Orkin
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

9.  IL-1β in eosinophil-mediated small intestinal homeostasis and IgA production.

Authors:  Y Jung; T Wen; M K Mingler; J M Caldwell; Y H Wang; D D Chaplin; E H Lee; M H Jang; S Y Woo; J Y Seoh; M Miyasaka; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2015-01-07       Impact factor: 7.313

10.  Towards an understanding of the adjuvant action of aluminium.

Authors:  Philippa Marrack; Amy S McKee; Michael W Munks
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

View more
  3 in total

Review 1.  Eosinophils: Nemeses of Pulmonary Pathogens?

Authors:  Kim S LeMessurier; Amali E Samarasinghe
Journal:  Curr Allergy Asthma Rep       Date:  2019-06-19       Impact factor: 4.806

2.  Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis.

Authors:  Milica M Grozdanovic; Christine B Doyle; Li Liu; Brian T Maybruck; Mark A Kwatia; Nethaji Thiyagarajan; K Ravi Acharya; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2020-01-23       Impact factor: 10.793

3.  Impact of controlled high-sucrose and high-fat diets on eosinophil recruitment and cytokine content in allergen-challenged mice.

Authors:  Caroline M Percopo; Morgan McCullough; Ajinkya R Limkar; Kirk M Druey; Helene F Rosenberg
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.